US election 2020: five IP stories from the year

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

US election 2020: five IP stories from the year

Trump v Biden 2020 Presidential Election

As the Trump v Biden battle goes to the wire, Managing IP recaps on election-relevant stories from 2020

With several key states yet to declare, the US election is going to the wire – and may not even be decided today.

While you wait, Managing IP brings you five articles from 2020 that are relevant to the election. 

We will bring you more coverage when we know whether Donald Trump or Joe Biden will be the next US president. 

Election 2020: how politics shapes the pharma patent debate

Just a week before election day, reporter Charlotte Kilpatrick spoke to in-house counsel about how politics has attempted to chip away at patent rights in the pharma industry.

Sources said that while the result won’t have a dramatic impact on patents, they are keeping an eye on how politics could shape the pharma patent debate in the future nonetheless.

Iancu: there’s a lot still to be done – for me, or the next director

Americas editor Patrick Wingrove spoke to USPTO director Andrei Iancu, whom Trump appointed in 2017. 

In the interview, Iancu set out his hopes for the office, particularly in diversity and inclusion, and his proudest accomplishments since taking office in 2018.

Exclusive: DoJ antitrust chief reveals plans to leave in 2021

In October, Patrick Wingrove revealed that the head of the US Department of Justice’s Antitrust Division would step down after Trump’s first term regardless of the election result.

Makan Delrahim later reflected on his tenure as he prepares to depart – probably for the private sector.

Survey: in-house counsel on the US patent landscape

Long before election day, reporter Rani Mehta surveyed more than 50 in-house counsel on the state of the US patent landscape.

Among other findings, the survey showed that respondents wanted to see more remote hearings in the future and that Delaware (which happens to be Biden's home state) was their preferred court to litigate in.

In-house survey: Trump takes early edge over Biden on IP

As part of the survey in May, Rani Mehta found that Trump had taken an early edge over Biden, at least when it came to IP matters. 

When asked which man's IP views were better for their business, 20% voted Trump, 11% picked Biden, and the remainder either didn't know or picked neither candidate. 



more from across site and SHARED ros bottom lb

More from across our site

Jennifer Che explains how taking on the managing director role at her firm has offered a new perspective, and why Hong Kong is seeing a life sciences boom
AG Barr acquires drinks makers Fentimans and Frobishers, in deals worth more than £50m in total
Tarun Khurana at Khurana & Khurana says corporates must take the lead if patent filing activity is to truly translate into innovation
Michael Moore, head of legal at Glean AI, discusses how in-house IP teams can use AI while protecting enforceability
Counsel for SEP owners and implementers are keeping an eye on the case, which could help shape patent enforcement strategy for years to come
Jacob Schroeder explains how he and his team secured victory for Promptu in a long-running patent infringement battle with Comcast
After Matthew McConaughey registered trademarks to protect his voice and likeness against AI use, lawyers at Skadden explore the options available for celebrities keen to protect their image
The Via members, represented by Licks Attorneys, target the Chinese company and three local outfits, adding to Brazil’s emergence as a key SEP litigation venue
The firm, which has revealed profits of £990,837, claims it is the disruptive force in the IP-legal industry
In the first of a two-parter, lawyers at Santarelli analyse the patentability of therapeutic inventions where publication of clinical trial protocols occurs before the application's filing date
Gift this article